GB1397035A - Process for the manufacture of isomorphinans - Google Patents

Process for the manufacture of isomorphinans

Info

Publication number
GB1397035A
GB1397035A GB3221073A GB3221073A GB1397035A GB 1397035 A GB1397035 A GB 1397035A GB 3221073 A GB3221073 A GB 3221073A GB 3221073 A GB3221073 A GB 3221073A GB 1397035 A GB1397035 A GB 1397035A
Authority
GB
United Kingdom
Prior art keywords
alkyl
proton
alkanoyl
carbamoyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3221073A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1397035A publication Critical patent/GB1397035A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1397035 Isomorphinan manufacture F HOFFMANN-LA ROCHE & CO AG 6 July 1973 [7 July 1972] 32210/73 Heading C2C Isomorphinans and salts thereof, are obtained by cyclizing an optionally substituted 1-benzyl 1,2,3,4,5,6,7,8-octahydro-isoquinoline, 1-benzyl- 1,2,3,4,6,7,8,9-octahydro-isoquinoline or 1- benzyl-decahydro-4a-isoquinolol in liquid phase with a mixture of boron trifluoride and a proton/ hydronium ion donor, and in optional sequence, isolating the isomorphina form from the morphinan form if desired, cleaving off or introducing a substituent if desired, resolving a racemate obtained into the optical antipodes if desired and, also if desired, converting a product obtained into a salt. In particular isomorphans of the general formula (I) wherein R 1 is C 1-8 alkyl, C 3-8 cycloalkyl, C 4-8 cycloalkyl-alkyl, C 2-8 alkenyl, C 2-8 alkynyl or C 1-8 alkanoyl and R 2 is C 1-8 alkyl, C 3-8 cycloalkyl, C 4-8 cycloalkylalkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 1-8 alkanoyl, benzoyl, phenyl-C 1-8 alkanoyl, C 1-8 -alkoxycarbonyl, phenoxycarbonyl, phenyl-C 1-8 alkoxycarbonyl, carbamoyl, C 1-8 alkyl-carbamoyl, or di-(C 1-8 alkyl) carbamoyl, and salts thereof, is obtained as above by cyclization of a starting material of the formula The term "proton/hydronium ion donor)" means the reagent acts either as a proton donor or as a proton and hydronium ion donor, and includes mineral acids, C 1-4 alkanols, C 1-4 alkanecarboxylic acids and C 1-4 nitroalkanes. Water can also be used, optionally with a hydrogen halide. The products have analgesic activity or are useful as intermediates for compounds having pharmacological activity. Reference has been directed by the Comptroller to Specification 1,233,193.
GB3221073A 1972-07-07 1973-07-06 Process for the manufacture of isomorphinans Expired GB1397035A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1020272 1972-07-07

Publications (1)

Publication Number Publication Date
GB1397035A true GB1397035A (en) 1975-06-11

Family

ID=4360534

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3221073A Expired GB1397035A (en) 1972-07-07 1973-07-06 Process for the manufacture of isomorphinans

Country Status (6)

Country Link
JP (1) JPS4942679A (en)
BE (1) BE801984A (en)
DE (1) DE2327737A1 (en)
FR (1) FR2192103B1 (en)
GB (1) GB1397035A (en)
NL (1) NL7308437A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631145C2 (en) * 1976-07-10 1981-09-24 Bayer Ag, 5090 Leverkusen Method and device for applying a layer of a liquid, foamable reaction mixture to a continuously conveyed support

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543514A (en) * 1967-08-25 1973-10-31 Hoffmann La Roche Process for the preparation of morphinane derivatives

Also Published As

Publication number Publication date
NL7308437A (en) 1974-01-09
FR2192103A1 (en) 1974-02-08
DE2327737A1 (en) 1974-01-24
FR2192103B1 (en) 1976-05-07
BE801984A (en) 1974-01-07
JPS4942679A (en) 1974-04-22

Similar Documents

Publication Publication Date Title
HU172963B (en) Process for producing n-bracket-4-piperidinyl-bracket closed-n-phenyl-amides and carbonates and pharmaceutical compositions containing them as active agents
DE2861955D1 (en) Malonic acid derivatives of sterically hindered piperidines, process for their preparation and stabilised organic matter
EG12483A (en) Process for preparing of novel imidazole derivatives used as fungicides
GB1397035A (en) Process for the manufacture of isomorphinans
AU3561171A (en) New diglycidyl derivatives of n-heterocyclic heterocyclic compounds, processes for their production andthe use thereof
GB1434405A (en) Phenyl-benzoic acid derivatives
ES8201169A1 (en) Quinazoline derivatives, process and intermediates for their preparation, medicaments containing them and their pharmaceutical use.
EP0309801A3 (en) Method of improving post-ischemic myocardial dysfunction using thromboxane a2 antagonists
UA5548A1 (en) Process for preparation of isoxazole derivatives
IL58828A (en) 3-bromoisoxazole derivatives,the preparation of 1-(3-bromoisoxazol-5-yl)-2-tert.butylaminoethanol and pharmaceutical compositions containing it
ES476160A1 (en) Hexahydroazepine, piperidine and pyrrolidine derivatives and processes for making and using them.
GB923336A (en) Improvements in or relating to steroids and the preparation thereof
SE7600340L (en) PROCEDURE FOR THE PREPARATION OF 2-AMINOIMIDAZOLIDE DERIVATIVES
GB1497723A (en) Octahydrobenzo-(c)(1,6)-naphthyridine derivative
Wolfe et al. The glutarimide dianion. A convenient new synthetic intermediate
GB1301367A (en)
FR1195013A (en) Process for the preparation of morphine derivatives
GB1199862A (en) A Process for the Manufacture of Dihydro-Benzdiaz[1,4]Epines
SU682335A1 (en) Method of welding cathode of an electrolyzer
GB1185432A (en) Process for Producing Benzomorphane Derivatives
AU231951B2 (en) Process for the production of 4-oxo-2-(halogen alkyl)-2, 3-dihydro- [benzo -1, 3-oxazines]
King et al. The opening of acyloxonium ions fused to rigid six-membered rings: an extension of the diaxial opening rule
AU3993458A (en) Process for the production of 4-oxo-2-(halogen alkyl)-2, 3-dihydro- [benzo -1, 3-oxazines]
CA549275A (en) Process of preparing oily butadiene polymers
CA633513A (en) Distillation process for mixture of pyridines

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed